Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Feb / Understanding Autism Spectrum Disorder
Neurology Genetics and epigenetics Neurology Screening and monitoring Molecular Pathology

Understanding Autism Spectrum Disorder

Four new studies contribute to our growing understanding of autism spectrum disorder

By Liv Gaskill 02/25/2021 Quick Read (pre 2022) 1 min read

Share

Methylation clues
Genetics may be heavily involved in ASD etiology – but now, researchers are also considering the role of paternal epigenetics. A team at Washington State University collected sperm samples from fathers of children with or without ASD to analyze changes in DNA methylation (1). Genome-wide analysis revealed 805 significant differential DNA methylation regions that could be used as biomarkers to predict paternal offspring autism susceptibility.

AI on autoantibodies
But what about mothers? Maternal autoantibodies of fetal brain proteins specific to ASD have previously been identified – a subtype now known as maternal autoantibody-related ASD (2). Researchers have developed a serological assay with machine learning to identify the reactivity patterns of ASD-specific maternal autoantibodies against eight proteins highly expressed in the fetal brain (3). The highly accurate test has the potential to predict a woman’s likelihood of having a child with ASD.

Beyond inheritance
Mosaic mutations that occur after conception may also be implicated in ASD. Using whole-genome sequencing to investigate mosaic mutations in the frontal cortices of participants with and without ASD, researchers have found that most brains have similar rates of “point” mosaic mutations – but, in participants with ASD, mutations were more likely to affect parts of the genome involved in brain function (4).

Copy number variants (CNVs) in mosaic patterns also differ in people with ASD (5). Larger CNVs (involving 25 percent or more of a chromosome) have been found in people with ASD and CNV size is linked to ASD severity. Surprisingly, smaller CNVs that are associated with ASD when found in all cells were no longer correlated when found in mosaic mutations.

It’s clear that no one factor causes ASD – and that only by stepping back and assessing each piece of the puzzle can we develop accurate screening and diagnostic tools.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. N Garrido et al., Clin Epigenetics, 13, 6 (2021). PMID: 33413568.
  2. KL Jones, J Van de Water, Mol Psychiatry, 24, 252 (2019). PMID: 29934547.
  3. A Ramirez-Celis, Mol Psychiatry, [Online ahead of print] (2021). PMID: 33483694.
  4. RE Rodin et al., Nat Neurosci, 24, 176 (2021). PMID: 3343219.
  5. MA Sherman et al., Nat Neurosci, 24, 197 (2021). PMID: 33432194.

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.